- Visibility 493 Views
- Downloads 468 Downloads
- Permissions
- DOI 10.18231/j.ijcbr.v.12.i.2.4
-
CrossMark
- Citation
Association of blood glucose-6-phosphate dehydrogenase and ferritin levels with glycated hemoglobin in patients with type 2 diabetes mellitus: A cross-sectional study
Introduction: Increased Glycated Hemoglobin (HbA1c) is a crucial indicator for inappropriate or inadequate diabetes care in patients with type 2 diabetes since it indicates inadequate long-term glycemic control. Serum ferritin, an indicator of iron stores, can be elevated due to chronic inflammation or iron overload, conditions that are not uncommon in diabetes. G6PD (Glucose-6-Phosphate Dehydrogenase) deficiency, while less directly related to diabetes control, can influence oxidative stress and redox status, potentially affecting overall diabetic complications.
Aims & Objectives: The study aims to investigate whether there is a significant correlation between Serum Ferritin, G6PD, and HbA1c in cases of type 2 diabetes mellitus and normal healthy controls.
Materials and Methods: This cross-sectional analytical study was conducted in the Department of Biochemistry and Endocrinology at KPC Medical College. 42 patients, aged 18 to 80 years, with type 2 diabetes mellitus, diagnosed according to the American Diabetes Association (ADA) criteria, were selected as cases. All are newly diagnosed patients without any comorbidities. An equal number of age and sex-matched healthy individuals were recruited as controls.
Results: Significant negative correlations have been observed both between G6PD and HbA1c [r = (-0.84), p<0.001] and G6PD and serum ferritin values [r = (-0.76), p<0.001]. A significant positive correlation has been observed between serum ferritin and HbA1c values (r =0.97, p<0.001). In this study, an increase in HbA1c is associated with a decrease in the serum levels of G6PD (negatively correlated) and an increase in serum ferritin (positively correlated).
Conclusion: Elevated ferritin can be used as a marker for glycemic control in diabetic patients, while G6PD status is relevant for managing oxidative stress-related complications.
References
- Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and Regional Diabetes Prevalence Estimates for 2019 and Projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th Edition. Diabetes Research and Clinical Practice [Internet]. 2019;157:107843.
- Valdez R, Yoon PW, Liu T, Khoury MJ. Family History and Prevalence of Diabetes in the U.S. Population: The 6-year results from the National Health and Nutrition Examination Survey (1999 2004). Diabetes Care [Internet]. 2007;30(10):2517–22.
- Saluja M, Suman CP, Saurabh Chittora, Meena D. Association of serum ferritin and glycated haemoglobin in patients of type 2 diabetes mellitus and its correlation with components of metabolic syndrome. Int J Res Med Sci. 2022;10(8):1657–7.
- Roglic G, Unwin N. Mortality attributable to diabetes: Estimates for the year 2010. Diabetes Res Clin Pract. 2010;87(1):15–9.
- Mohan V, Pradeepa R. Epidemiology of Type 2 Diabetes in India. Indian J Ophthalmol. 2021;69(11):2932.
- Khan MI, Weinstock RS. Carbohydrates. In: McPherson RA, Pincus MR, eds. Henry’s Clinical Diagnosis. and Management Laboratory Methods. 22nd Philadelphia, PA (edn): Saunders Elsevier, 2011.
- Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation. 2011; Available from: https://pubmed.ncbi.nlm.nih.gov/26158184
- Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: A systematic review and meta-analysis. Blood Cells, Mol Dis. 2009;42(3):267–78.
- Leong A, Jun V, Wang C, Chai JF, Rajkumar Dorajoo, Heng CK, et al. Association ofG6PDvariants with hemoglobin A1c and impact on diabetes diagnosis in East Asian individuals. BMJ Open Diabetes Res Care. 2020;8(1):e001091–1.
- Gupte SA. Glucose-6-phosphate dehydrogenase: a novel therapeutic target in cardiovascular diseases. Curr Opin Investig Drugs. 2008;9(9):993-1000.
- Rajpathak S, Ma J, Manson J, Willett WC, Hu FB. Iron Intake and the Risk of Type 2 Diabetes in Women: A prospective cohort study. Diabetes Care. 2006;29(6):1370–6.
- Jiang R, Ma J, Ascherio A, Stampfer MJ, Willett WC, Hu FB. Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: a prospective cohort study. Am J Clin Nutr. 2004;79(1):70–5.
- Chen L, Li Y, Zhang F, Zhang S, Zhou X, Ji L. Elevated serum ferritin concentration is associated with incident type 2 diabetes mellitus in a Chinese population: A prospective cohort study. Diabetes Res Clin Pract. 2018;139:155–62.
- Kunutsor SK, Apekey TA, Walley J, Kain K. Ferritin levels and risk of type 2 diabetes mellitus: an updated systematic review and meta- analysis of prospective evidence. Diabetes Metab Res Rev. 2013;29(4):308–18.
- Ripoli C, Maria Rossella Ricciardi, Maria Rosaria Angelo, Ripoli D. Quantifying the effect of glucose 6-phosphate dehydrogenase deficiency on glycated hemoglobin values in children and adolescents with type 1 diabetes. Sci Rep. 2024;14(1):7311.
- Pinna A, Contini EL, Carru C, Solinas G. Glucose-6-phosphate dehydrogenase deficiency and diabetes mellitus with severe retinal complications in a Sardinian population, Italy. Int J Med Sci. 2013;10(13):1907–13.
- Chang YS, Hsiao LY, Lin CY, Shih MC, Hsieh MC, Chang JG. Fasting glucose-to-HbA1c ratio is a good indicator of G6PD Anand et al. / International Journal of Clinical Biochemistry and Research 2025;12(2):84-89 89 deficiency, but not thalassemia, in patients with type 2 diabetes mellitus. Clin Chim Acta. 2020;506:9–15.
- Mahmoud AA, Nor El -Din AKA. Glucose-6-Phosphate Dehydrogenase Activity and Protein Oxidative Modification in Patients with Type 2 Diabetes Mellitus. J Biomark. 2013;2013:430813.
- Son NE. Influence of ferritin levels and inflammatory markers on HbA1c in the Type 2 Diabetes mellitus patients. Pak J Med Sci. 2019;35(4):1030–5.
- Engwa GA, Unaegbu M, Unachukwu MN, Njoku MC, Agbafor KN, Mbacham WF, et al. Low serum ferritin and G6PD deficiency as potential predictors of anaemia in pregnant women visiting Prime Care Hospital Enugu Nigeria. BMC Res Notes. 2017;10(1):721.
How to Cite This Article
Vancouver
Anand A, Bhattacharyya I, Bhattacharya A, Saha P, Sanyal D, Mandal P, Ghosh S, Chettri D. Association of blood glucose-6-phosphate dehydrogenase and ferritin levels with glycated hemoglobin in patients with type 2 diabetes mellitus: A cross-sectional study [Internet]. Int J Clin Biochem Res. 2025 [cited 2025 Oct 05];12(2):84-89. Available from: https://doi.org/10.18231/j.ijcbr.v.12.i.2.4
APA
Anand, A., Bhattacharyya, I., Bhattacharya, A., Saha, P., Sanyal, D., Mandal, P., Ghosh, S., Chettri, D. (2025). Association of blood glucose-6-phosphate dehydrogenase and ferritin levels with glycated hemoglobin in patients with type 2 diabetes mellitus: A cross-sectional study. Int J Clin Biochem Res, 12(2), 84-89. https://doi.org/10.18231/j.ijcbr.v.12.i.2.4
MLA
Anand, Ayush, Bhattacharyya, Ipsita, Bhattacharya, Ankita, Saha, Pinaki, Sanyal, Debmalya, Mandal, Projesh, Ghosh, Soumyajit, Chettri, Dikcha. "Association of blood glucose-6-phosphate dehydrogenase and ferritin levels with glycated hemoglobin in patients with type 2 diabetes mellitus: A cross-sectional study." Int J Clin Biochem Res, vol. 12, no. 2, 2025, pp. 84-89. https://doi.org/10.18231/j.ijcbr.v.12.i.2.4
Chicago
Anand, A., Bhattacharyya, I., Bhattacharya, A., Saha, P., Sanyal, D., Mandal, P., Ghosh, S., Chettri, D.. "Association of blood glucose-6-phosphate dehydrogenase and ferritin levels with glycated hemoglobin in patients with type 2 diabetes mellitus: A cross-sectional study." Int J Clin Biochem Res 12, no. 2 (2025): 84-89. https://doi.org/10.18231/j.ijcbr.v.12.i.2.4